Hotchkis & Wiley Capital Management
MD icon

Hotchkis & Wiley Capital Management’s Pediatrix Medical MD Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-156,510
Closed -$4.45M – 505
2021
Q3 		$4.45M Sell
156,510
-14,930
-9% -$455K 0.01% 355
2021
Q2 		$5.17M Buy
171,440
+10,940
+7% +$323K 0.02% 314
2021
Q1 		$4.09M Buy
160,500
+11,590
+8% +$297K 0.01% 372
2020
Q4 		$3.65M Sell
148,910
-129,820
-47% -$2.44M 0.01% 317
2020
Q3 		$4.54M Sell
278,730
-29,400
-10% -$547K 0.02% 212
2020
Q2 		$5.27M Sell
308,130
-62,640
-17% -$929K 0.02% 147
2020
Q1 		$4.32M Buy
370,770
+117,270
+46% +$2.42M 0.02% 178
2019
Q4 		$7.04M Buy
253,500
+12,300
+5% +$308K 0.02% 196
2019
Q3 		$5.46M Buy
241,200
+6,830
+3% +$156K 0.02% 209
2019
Q2 		$5.91M Buy
+234,370
New +$6.3M 0.02% 153

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management's MD Position: Q4 2021 in Review

Hotchkis & Wiley Capital Management sold out of Pediatrix Medical (MD) in Q4 2021, closing a stake of 156,510 shares — an estimated $4.45M sold.

Hotchkis & Wiley Capital Management first reported a position in MD in Q2 2019 and held it in 10 quarters. The position peaked at $7.04M in Q4 2019. 204 funds tracked by Wall St. Rank hold MD as of Q4 2021.

  • Hotchkis & Wiley Capital Management reported no remaining Pediatrix Medical position as of Q4 2021 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 156,510 Pediatrix Medical shares in Q4 2021, an estimated $4.45M.
  • Hotchkis & Wiley Capital Management first reported a position in Pediatrix Medical in Q2 2019 and held it in 10 quarters.
  • Hotchkis & Wiley Capital Management's Pediatrix Medical position peaked at $7.04M in Q4 2019.
  • 204 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2021.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.